Clogged Brain Drains: The Alzheimer's Warning Sign Hiding in Plain Sight on MRI Scans

Banks drag indexes lower despite earnings beats as Trump credit card cap spooks financials

The quick scan: US stocks retreated from record territory on Tuesday, January 14th, as financial stocks plunged despite better-than-expected earnings, weighed down by President Trump's proposal to cap credit card interest rates at 10% for one year. The selling in banks offset strength in technology and consumer sectors, snapping the recent winning streak.

S&P 500: -0.19% to 6,963.74 – The broad market index pulled back from Monday's record close as financials fell 1.7%, the sector's worst day since mid-December, offsetting gains in consumer staples and tech
Dow Jones: -0.80% to 49,191.99 – Blue-chip stocks shed 398 points, led lower by JPMorgan's 4.2% plunge despite beating earnings estimates, as the bank's CFO signaled the industry would push back against Trump's credit card rate cap
NASDAQ: -0.10% to 23,709.87 – The tech-heavy index eked out a modest loss, holding up better than the broader market as semiconductor and software stocks showed resilience despite financial sector weakness.

What's driving it: Tuesday's session was dominated by the banking sector's reaction to Trump's Friday proposal to cap credit card interest rates – a move that would directly hit profits at issuers like JPMorgan, Capital One, and American Express. JPMorgan fell 4.2% despite fourth-quarter earnings of $5.23 per share (vs. $5 expected) on revenue of $46.77 billion (vs. $46.2B expected), with CFO Jeremy Barnum warning the industry would resist the cap. American Express dropped 3%, Capital One fell 2.5%, and Bank of America shed 2%. Beyond financials, Delta Air Lines tumbled 5% on mixed results, while L3Harris Technologies surged 13% on plans to IPO its missile solutions business. The divergence between financial sector weakness and other areas' strength created a choppy session where the S&P 500 traded positive early before selling accelerated into the close.

Bottom line: For L-Plate Retirees, Tuesday's action demonstrates how quickly policy proposals can upend sector leadership. Banks that led early 2026 gains suddenly became laggards when political winds shifted – a reminder that sector rotation often happens faster than investors can react. The fact that JPMorgan fell 4% despite beating earnings shows that forward guidance and regulatory uncertainty matter more than backward-looking results. This is where diversification earns its keep: while financials dragged the S&P 500 lower, tech held relatively steady, and your balanced portfolio absorbed the sector-specific shock without catastrophic damage. Just as your brain's drainage system needs multiple pathways to clear waste efficiently, your portfolio needs exposure across sectors so weakness in one area doesn't clog the entire system. When one sector's "drains" get blocked by policy uncertainty, other sectors keep your wealth flowing toward long-term goals.

Your Brain Has Drains (And They Might Be Clogged)

The scoop: You've probably heard of "brain drain" in the economic sense – talented people leaving for better opportunities elsewhere. But your brain has actual drains, microscopic pathways that flush out metabolic waste, toxic proteins, and cellular debris while you sleep.

And according to new research from Singapore, when these drains get clogged, it might be one of the earliest warning signs of Alzheimer's disease – appearing years before memory problems become obvious.

Researchers at Nanyang Technological University studied nearly 1,000 Singaporeans and discovered something striking: people showing early signs of Alzheimer's consistently had enlarged perivascular spaces – essentially, backed-up brain drains visible on routine MRI scans. The condition appears before significant cognitive decline, potentially offering a window for intervention that current diagnostic methods miss entirely.

This matters because Alzheimer's doesn't announce itself. By the time memory problems become impossible to ignore, the disease has typically been developing for years, maybe decades. Finding markers that appear earlier – especially markers visible on scans doctors already use – could transform how we approach brain health in later life.

What Your Brain's Drainage System Actually Does

Your brain generates waste constantly. Metabolic byproducts, damaged proteins, cellular debris – all the detritus of a working nervous system. Unlike other organs, your brain doesn't have a traditional lymphatic system to handle this cleanup. Instead, it uses something called the glymphatic system.

The glymphatic system works primarily during sleep, using cerebrospinal fluid to flush waste through microscopic channels surrounding blood vessels. These channels – perivascular spaces – act like drains, carrying toxic substances including beta-amyloid and tau proteins (the hallmark proteins that accumulate in Alzheimer's) out of brain tissue.

When this system works efficiently, waste clears smoothly. But conditions like chronic high blood pressure and arterial stiffening can disrupt the process. The vessels stiffen, blood flow becomes less pulsatile, and drainage slows. Waste starts accumulating. The drainage channels themselves begin to enlarge, becoming visible on MRI scans as enlarged perivascular spaces.

Think of it like your kitchen sink. When the pipes work properly, water and debris drain invisibly. When something clogs the system, water backs up, the basin fills, and the problem becomes visible. Enlarged perivascular spaces are your brain's version of a backed-up sink.

The Singapore Study's Key Findings

The NTU researchers, led by Associate Professor Nagaendran Kandiah and 23-year-old medical student Justin Ong, analyzed MRI scans from 979 participants. They compared people with mild cognitive impairment – the transitional stage between normal aging and dementia – against those with normal cognition.

The results were clear: people with mild cognitive impairment showed significantly more enlarged perivascular spaces than those without cognitive issues. But the researchers didn't stop there. They also measured seven established Alzheimer's biomarkers in participants' blood, including beta-amyloid and tau proteins.

Among participants with enlarged perivascular spaces, four of the seven biomarkers appeared more frequently. This means people with visible drain clogging on MRI scans were more likely to have amyloid plaques, tau tangles, and other signs of Alzheimer's pathology developing in their brains.

Here's what makes this particularly significant: the researchers also looked at white matter damage, currently the most common MRI marker doctors use to assess dementia risk. White matter damage showed associations with six of the seven biomarkers. But among people with mild cognitive impairment, the link between Alzheimer's biomarkers and enlarged perivascular spaces was actually stronger than the link with white matter damage.

This suggests that clogged brain drains might appear earlier in the disease process than the damage doctors typically look for.

Why This Changes the Early Detection Game

Currently, confirming Alzheimer's requires either expensive specialized scans (amyloid PET imaging) or invasive procedures (spinal taps to measure biomarkers in cerebrospinal fluid). These aren't routine screening tools – they're confirmatory tests used after symptoms appear.

Enlarged perivascular spaces, by contrast, show up on standard MRI scans that doctors already order when evaluating memory concerns. No additional test needed. No extra cost. Just another data point on an existing scan that could indicate elevated Alzheimer's risk before obvious symptoms develop.

Dr. Rachel Cheong, a senior geriatric specialist in Singapore, noted that this discovery could help identify at-risk individuals before major symptoms manifest. Dr. Chong Yao Feng, a neurologist at National University Hospital, pointed out that the research also challenges how doctors think about Alzheimer's and vascular brain disease – conditions historically treated as separate problems that this research suggests might work together to cause cognitive decline.

The Limitations You Need to Understand

Before you panic-call your doctor demanding to know about your perivascular spaces, understand the limitations. This was a cross-sectional study – a snapshot in time – not a longitudinal study following people for years. The researchers plan to track participants over time to confirm whether enlarged perivascular spaces reliably predict who develops Alzheimer's dementia, but those results aren't available yet.

Also, seeing enlarged perivascular spaces on your MRI doesn't mean you have or will develop Alzheimer's. It's a risk marker, not a diagnosis. Many factors influence drainage function – blood pressure, sleep quality, vascular health, genetics. Some people with enlarged spaces may never develop dementia. Some without them might.

The real value isn't in individual diagnosis but in population-level screening and research. If enlarged perivascular spaces consistently appear early in Alzheimer's development, they become a tool for identifying people who might benefit from early intervention – lifestyle changes, blood pressure management, sleep optimization, or future treatments targeting the disease before extensive damage occurs.

What You Can Actually Do About It

You can't directly unclog your brain's drainage system the way you'd snake a pipe. But you can optimize the conditions that keep drainage functioning well.

Manage blood pressure aggressively. Chronic hypertension stiffens blood vessels, impairing the pulsatile flow that drives glymphatic drainage. Keeping blood pressure controlled protects not just your heart but your brain's waste-removal system.

Prioritize sleep quality, not just quantity. The glymphatic system works primarily during sleep, particularly deep sleep. Seven hours of fragmented, poor-quality sleep won't clear waste as effectively as six hours of consolidated, restorative sleep. If you snore heavily or wake frequently, consider sleep apnea screening.

Stay physically active. Exercise improves vascular health, promotes better sleep, and may enhance glymphatic function. You're not just building cardiovascular fitness – you're maintaining the plumbing that keeps your brain clean.

Control vascular risk factors. Diabetes, high cholesterol, smoking – everything that damages blood vessels potentially compromises brain drainage. Managing these isn't just about preventing strokes; it's about maintaining the infrastructure that prevents toxic protein accumulation.

The researchers emphasize that if future studies in other populations reach similar conclusions, identifying clogged brain drains on MRI could become a routine screening tool. We're not there yet, but the direction is promising.

Actionable Takeaways for L-Plate Retirees

• Don't panic if you've had an MRI: Enlarged perivascular spaces are common and don't automatically mean Alzheimer's is developing. They're a risk marker requiring context, not a diagnosis requiring immediate action.

• Ask about it at your next cognitive assessment: If you're getting an MRI for memory concerns, ask your doctor whether your scan shows enlarged perivascular spaces and what that means in context with your other symptoms and risk factors.

• Treat blood pressure control as brain protection: If you've been casual about blood pressure management, this research gives you another reason to take it seriously. Target 120/80 or whatever your doctor recommends – your brain's drainage depends on healthy vessels.

• Make sleep quality a priority, not an afterthought: If you're getting "enough" hours but waking unrefreshed, or if you snore heavily, get evaluated for sleep disorders. Your brain does its most important cleaning while you're properly asleep.

• Understand this is early research: The NTU team is still following participants to confirm predictions. Don't make major health decisions based solely on perivascular space findings – context from other symptoms and biomarkers matters enormously.

• Stay informed about emerging research: As longitudinal data becomes available, we'll understand better whether this marker reliably predicts Alzheimer's development. Keep asking your doctor about new developments in early detection.

Your Turn:
If a routine brain scan could reveal Alzheimer's risk years before symptoms appear, would you want to know – or would the uncertainty feel worse than not knowing?
Does learning that your brain has a "cleaning system" that works primarily during sleep change how you think about sleep quality?
What would you actually do differently if a doctor told you your brain scans showed elevated Alzheimer's risk markers but no current symptoms?

👉 Hit reply and share your thoughts – your answers could inspire fellow readers in future issues.

If this breakdown of AI health assistants helped you understand what these tools can (and can't) do for your health, consider shouting me a coffee shout on Ko-fi. Your contribution helps us cut through healthcare hype to deliver practical insights that keep you safe, informed, and in control of your wellbeing.